cailynn

Yeni makale yazdı

4 günler önce - çevirmek

Overcoming Drug Delivery Barriers with Advanced Vesicular Systems | #lipid-based vesicular delivery

Overcoming Drug Delivery Barriers with Advanced Vesicular Systems

Overcoming Drug Delivery Barriers with Advanced Vesicular Systems

Overcoming Drug Delivery Barriers with Advanced Vesicular Systems

Beğen

Yorum Yap

Paylaş

Yeni makale yazdı

4 günler önce - çevirmek

Liposomes Address Critical Gaps in Antiviral Drug Delivery | #liposome solutions

Liposomes Address Critical Gaps in Antiviral Drug Delivery

Liposomes Address Critical Gaps in Antiviral Drug Delivery

Poor bioavailability, unstable therapeutics, limited tissue penetration, and off-target toxicity continue to constrain antiviral R&D. Liposome-based delivery systems offer researchers a flexible route to overcome these barriers.

Beğen

Yorum Yap

Paylaş

Yeni makale yazdı

4 günler önce - çevirmek

From Cell Models to Drug Insights: Advancing Stem Cell Research | #stem cell research

From Cell Models to Drug Insights: Advancing Stem Cell Research

From Cell Models to Drug Insights: Advancing Stem Cell Research

Stem cell research is reshaping disease modeling and drug discovery, but reproducibility, model relevance, and cell characterization remain major hurdles. Integrated stem cell platforms can help researchers close these gaps.

Beğen

Yorum Yap

Paylaş

Yeni makale yazdı

4 günler önce - çevirmek

Overcoming the In-House Bottleneck: Why the iPSC Differentiation Strategy Is Shifting Toward Expert Partnerships | #ipsc differentiation

Overcoming the In-House Bottleneck: Why the iPSC Differentiation Strategy Is Shifting Toward Expert Partnerships

Overcoming the In-House Bottleneck: Why the iPSC Differentiation Strategy Is Shifting Toward Expert Partnerships

Overcoming the In-House Bottleneck: Why the iPSC Differentiation Strategy Is Shifting Toward Expert Partnerships

Beğen

Yorum Yap

Paylaş

Yeni makale yazdı

4 günler önce - çevirmek

Overcoming Preclinical Hurdles in Neuro-Drug Discovery | #neuro-drug discovery

Overcoming Preclinical Hurdles in Neuro-Drug Discovery

Overcoming Preclinical Hurdles in Neuro-Drug Discovery

The translational gap in CNS drug discovery drives high clinical failure rates. Transitioning from traditional 2D assays to human iPSC-derived 3D disease models and automated phenotypic screening offers a scalable path to identify robust neuro-therapeutic candidates.

Beğen

Yorum Yap

Paylaş

Daha fazla Mesajları yükle

Bilgi

8 Mesajları
Dişi

0

0

1

aliraza121

0

Gruplar

0